Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Northeastern University
- New England HERC
- University of North Carolina at Chapel Hill
- Yale School of Medicine - Department of Genetics
- Cornell University
- George Washington University
- Queen Mary University of London
- Stanford University
- The Jiang Lab, The Icahn School of Medicine at Mount Sinai
- University of California, Los Angeles
- University of Copenhagen
- University of Kansas Medical Center
- 2 more »
- « less
-
Field
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline
-
(fibrosis). The lab has ample preliminary data showing that an immune-stromal cell axis is central to the repair/damage turning point, yet much remains to be elucidated. As a brand-new lab opening in
-
fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical
-
underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research
-
serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance